News

Data about the Activity of Moldovan Commercial Banks on July 31, 2025Dr. Sándor Csány: Being the 4th largest, OTP in Moldova will grow both organically as well as through possible mergers and acquisitions It seems to be a place, but it is notScott HOCKLANDER: For me, the persistence of Moldovan citizens is not only a learned lesson, but also a great exampleSorin MASLO: "The year 2022 was a turning point for the "Cricova" Wine Combine, the turnover increased by almost 25%"Deposit rates are at their peak. Market conjuncture or Why banks need individuals’ depositsValeriu LAZĂR: "If the state does not support business today, tomorrow it will have no one to collect taxes from.Chisinau Airport as a reflection of statehoodMonetary measures against non-monetary inflationBanks as the fulcrum of the economy: they have increased profits and are preparing for the challenges of the 2H 2022The Ministry of Finance and investors in the State Securities market at the peak of placement volumesThe banking market: turmoil and increased demand. No panicIs Moldova ready for the economic consequences of the war in the neighboring country?Are we heading for hyperinflation? It all depends on the correct diagnosis and the prescribed treatmentWhat is happening in the Government Securities Market and what does the National Bank have to do with it?The wine industry is on the verge of a revolution: Is the industry-specific law bankrupting enterprises? The trap for the oil products marketLászló DIÓSI: Foreign investments come to Moldova due to banking system stabilityWhen there is no program with the IMF, we issue are government securities ...Nikolay BORISSOV: “Acquisition of Moldindconbank is the best procurement in the Moldovan market, albeit the most risky one”Oil Ping Pong GamesBanking 2020 - pandemic, profitableWeird 2020: humility, depression, rebellion, accepting a new realityThe Hunger Games of the foreign exchange marketHow to tame liquidity?Veaceslav IONITA: The government killed the business, but flirted with the populationPeople and Business: Natural and Unnatural SelectionAlexandru BURDEINII: Being ethical becomes vital in business nowadaysMoldova’s Key Macroeconomic IndicatorsPrices at filling stations

The Moldovan government on Thursday approved a number of new personnel changes, dismissing and appointing several more secretaries of state.

The Moldovan government on Thursday approved a number of new personnel changes, dismissing and appointing several more secretaries of state.

In particular, Vadim Gumene was appointed the new Secretary of State of the Ministry of Economy, Alexandru Oprea, State Secretary of the Ministry of Internal Affairs, and Adrian Cazacu-Tigay, Secretary of the Ministry of Education and Research. At the same time, Igor Curov and Vasile Cusca were dismissed from the post of state secretaries of the Ministry of Health, Labor and Social Protection, and Valentina Tapes - from the post of State Secretary of the Ministry of Agriculture, Regional Development and Environment. Also, Rostislav Rotari was dismissed from the post of Secretary General of the Ministry of Defense, and Sergiu Paiu was dismissed from his post as head of the General Police Inspectorate. A number of decisions concerned the leadership of the Agency for Medicines and Medical Devices of Moldova. In particular, in order to enforce the judgment, the government first reinstated Eremei Priseajniuc as CEO of the Agency for Medicines and Medical Devices and decided to pay him his salary for the entire period after his resignation on November 11, 2020. Due to the reinstatement of the former director, the current CEO of the Agency for Medicines and Medical Devices of Moldova Silvia Cebotari was dismissed. Herewith, immediately, Eremei Priseajniuc was dismissed from the post of general director of the agency on the basis of the submitted application. By a new decision of the Cabinet of Ministers, Lina Gudima was appointed Deputy Director General of the Agency, who will be Acting Director General of the Agency for Medicines and Medical Devices of Moldova until the appointment of its new head. Until now, Lina Gudima headed the department of pharmacovigilance and clinical trials at the agency. //12.08.2021 — InfoMarket.

News on the subject